ArticleCell reports2021

Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING.

Marine Bruand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.